Tarsus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.637; its P/E ratio is -7.08; Tarsus Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 13.08M	$ 1.87M	-	$ 2.50M	$ 10.00M
Gross Profit	$ 11.86M	$ 1.49M	-	$ 2.50M	$ 9.10M
EBIT	$ -40.03M	$ -37.53M	$ -29.89M	$ -25.03M	$ -15.28M
EBITDA	$ -39.16M	-	$ -30.68M	$ -26.33M	$ -15.89M
Net Income Common Stockholders	$ -41.90M	$ -39.15M	$ -31.42M	$ -23.42M	$ -13.84M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 227.44M	$ 246.88M	$ 178.23M	$ 201.22M	$ 217.03M
Total Assets	$ 265.49M	$ 268.33M	$ 188.93M	$ 210.02M	$ 227.86M
Total Debt	$ 29.82M	$ 29.71M	$ 24.61M	$ 24.52M	$ 19.43M
Net Debt	$ -197.62M	$ -217.18M	$ -153.62M	$ -176.70M	$ -197.59M
Total Liabilities	$ 68.50M	$ 54.67M	$ 41.20M	$ 37.81M	$ 34.96M
Stockholders Equity	$ 196.99M	$ 213.66M	$ 147.73M	$ 173.40M	$ 192.90M
Cash Flow	-
Free Cash Flow	$ -39.34M	-	$ -24.61M	$ -22.31M	$ -11.00M
Operating Cash Flow	$ -39.34M	$ -32.36M	$ -23.83M	$ -21.97M	$ -10.87M
Investing Cash Flow	$ 17.85M	$ 47.37M	$ 64.09M	$ 11.29M	$ -87.22M
Financing Cash Flow	$ 19.76M	$ 104.89M	$ 510.00K	$ 5.01M	$ 264.00K

Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History

Income Statement >

Tarsus Pharmaceuticals Debt to Assets

Balance Sheet >

Tarsus Pharmaceuticals Cash Flow

Cash Flow >

Tarsus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing